Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DR26F8Q5Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,836
Award facts
- Contract value 100% obligated
- $12,836.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $12,836.26 delivery order to Amerisourcebergen Drug Corp on June 3, 2026, for VRAYLAR 3 MG Capsule 30-count units, with ultimate completion on June 4, 2026.
Place of performance is Conshohocken, PA. The order is priced firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and serves as the execution entity for DLA pharmaceutical distribution, competing on a full and open basis across Defense Health Agency and military medical facilities globally.
Quick answers
Who was awarded contract SPE2DR26F8Q5Z?
SPE2DR26F8Q5Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 3, 2026.
How much is contract SPE2DR26F8Q5Z worth?
The government has obligated $12,836 on SPE2DR26F8Q5Z.
Is contract SPE2DR26F8Q5Z an order under another contract?
Yes. SPE2DR26F8Q5Z is a delivery order under SPE2DR25D3022, an indefinite delivery contract.
Was contract SPE2DR26F8Q5Z competed?
The extent of competition for SPE2DR26F8Q5Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award